Skip to content

Improve Outcomes for Older Allogeneic Transplant Recipients

Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05612789
Enrollment
72
Registered
2022-11-10
Start date
2023-02-15
Completion date
2031-06-01
Last updated
2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allogeneic Transplantation

Brief summary

This is an interventional pilot study to determine whether implementation of a supervised exercise program can improve outcomes in subjects undergoing allogeneic HCT. The primary objective is to determine feasibility. Up to 60-72 evaluable subjects will be enrolled. Evaluable subjects are defined as those participating in the exercise intervention.

Interventions

BEHAVIORALExercise Program (Cohort A Prehab)

Pre-frail and frail potential HCT recipients 60 years and older will participate in a supervised exercise program from the time of enrollment up until HCT admission. Exercise compliance will be measured in part through physical activity trackers.from time of discharge from HCT until day +100 post-HCT. All HCT recipients 60 years and older will participate in a supervised exercise program from the time of discharge from HCT admission until day +100 post-HCT. Exercise compliance will be measured in part through physical activity trackers.

BEHAVIORALExercise Program (Cohort B Rehab)

All HCT recipients 60 years and older will participate in a supervised exercise program from the time of discharge from HCT admission until day +100 post-HCT. Exercise compliance will be measured in part through physical activity trackers.

Sponsors

Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Cohort A (Prehab) 1. Age 60 years or older. 2. Planned allogeneic HCT in the next 1-6 months. 3. Hematological malignancy as the indication for HCT. 4. Pre-frail or frail by Fried frailty phenotype. Cohort B (Rehab) 1. Age 60 years or older. 2. Planned allogeneic HCT or HCT within the last 30 days. 3. Hematological malignancy as the indication for HCT.

Exclusion criteria

Cohorts A and B 1\. Comorbid disability or illness that prevents safe exercise.

Design outcomes

Primary

MeasureTime frame
Proportion of enrolled subjects who participate in the supervised exercise programFrom 3 months prior to HCT to 100 days after HCT
Median number of exercise sessions delivered pre-HCT and post-HCT.From 3 months prior to HCT to 100 days after HCT

Secondary

MeasureTime frame
6-month and 1-year overall mortalityFrom day 0 of HCT to 6 months and 1-year] 6. 1-year and 2-year OS
Hospital LOS for HCTFrom date of randomization until the date of first documented discharge from the hospital, assessed up to 100 months
1-year and 2-year PFSFrom day 0 of HCT to 1-year and 2-years
1-year and 2-year OSFrom day 0 of HCT to 1-year and 2-years
Rate of readmissionFrom time of discharge from initial hospital stay up through 1-2 years after HCT

Countries

United States

Contacts

Primary ContactJacqui Rick
Jacqui.Rick@pennmedicine.upenn.edu2152209675

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026